Eli Lilly
Eli Lilly and Company is an American pharmaceutical company, founded in 1876, that is known for its contributions to the development of various medications across multiple therapeutic areas, including diabetes, oncology, and immunology. The company has gained recognition for its diabetes treatment, Mounjaro, which is part of the GLP-1 receptor agonist class. Eli Lilly is committed to improving patient outcomes through innovative products and has a strong focus on research and development.
Global Media Ratings
Countries Mentioned
No country-level mention data available.
Interactive World Map
Each country's color is based on "Mentions" from the table above.
Recent Mentions
United States:
Eli Lilly is the maker of Zepbound, a drug involved in a clinical trial comparing obesity treatments.
6
Romania:
Eli Lilly is a pharmaceutical company that recently presented the results of a phase 3 clinical study regarding Orforglipron, an experimental oral medication for treating type 2 diabetes.
7
Italy:
Eli Lilly announced the results of a Phase 3 study of its pill Orforglipron that could be as effective as popular injectable drugs Mounjaro and Ozempic.
8
Canada:
Eli Lilly and Company’s experimental pill worked as well as blockbuster drug Ozempic to lower weight and blood sugar in a trial of diabetes patients.
8
Switzerland:
Eli Lilly plans to build four new factories in the USA to meet the demand for their products.
7
Israel:
Eli Lilly is the American pharmaceutical company developing the experimental drug Lepodisiran.
7
Bulgaria:
Eli Lilly is preparing to reveal results from new clinical trials for an experimental weight loss and diabetes pill.
8
Switzerland:
Eli Lilly announced plans to begin construction of four new 'Mega-Factories' in the USA this year.
6
Denmark:
Eli Lilly has intensified the competition for cheaper weight loss medicine by lowering the price of its cheapest weight loss drug Zepbound.
7
United States:
Eli Lilly is the maker of blockbuster weight loss and diabetes drugs Zepbound and Mounjaro.
8